Q2 EPS Forecast for Axsome Therapeutics Increased by Analyst
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Stock analysts at William Blair upped their Q2 2025 earnings per share (EPS) estimates for shares of Axsome Therapeutics in a report released on Monday, May 5th. William Blair analyst M. Minter now anticipates that the company will post earnings of ($0.99) per share for the quarter, […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Stock analysts at William Blair upped their Q2 2025 earnings per share (EPS) estimates for shares of Axsome Therapeutics in a report released on Monday, May 5th. William Blair analyst M. Minter now anticipates that the company will post earnings of ($0.99) per share for the quarter, […]
